Low-dose IL-2 therapy invigorates CD8+ T cells for viral control in systemic lupus erythematosus
Abstract
Autoimmune diseases are often treated by glucocorticoids and immunosuppressive drugs that could increase the risk for infection, which in turn deteriorate disease and cause mortality. Low-dose IL-2 (Ld-IL2) therapy emerges as a new treatment for a wide range of autoimmune diseases. To examine its influence on infection, we retrospectively studied 665 patients with systemic lupus erythematosus (SLE) including about one third receiving Ld-IL2...
Paper Details
Title
Low-dose IL-2 therapy invigorates CD8+ T cells for viral control in systemic lupus erythematosus
Published Date
Oct 7, 2021
Journal
Volume
17
Issue
10
Pages
e1009858 - e1009858
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History